Why Are Shares Of IO Biotech Plummeting?

Benzinga03-31

IO Biotech's sell-off is being treated as an insolvency event, not a routine small-cap biotech de-risking, after the company filed for Chapter 7 bankruptcy and said it will cease operations in ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2623533639?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/31/Genetic-Research-And-Biotech-Science-Con_0.jpeg?optimize=medium&dpr=2&auto=webp&width=260","is_english":true,"pubTime":"2026-03-31 23:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2623533639","market":"us","top_or_hot":-1,"title":"Why Are Shares Of IO Biotech Plummeting?","media":"Benzinga","content":"<div>\n<p>IO Biotech's sell-off is being treated as an insolvency event, not a routine small-cap biotech de-risking, after the company filed for Chapter 7 bankruptcy and said it will cease operations in ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/26/03/51572463/why-are-shares-of-io-biotech-plummeting\">Source Link</a>\n\n</div>\n","source":"benzinga_hot_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Are Shares Of IO Biotech Plummeting?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Are Shares Of IO Biotech Plummeting?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-31 23:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/trading-ideas/movers/26/03/51572463/why-are-shares-of-io-biotech-plummeting><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>IO Biotech's sell-off is being treated as an insolvency event, not a routine small-cap biotech de-risking, after the company filed for Chapter 7 bankruptcy and said it will cease operations in ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/26/03/51572463/why-are-shares-of-io-biotech-plummeting\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/03/51572463/why-are-shares-of-io-biotech-plummeting","article_id":"2623533639","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/31/Genetic-Research-And-Biotech-Science-Con_0.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/03/51572463/why-are-shares-of-io-biotech-plummeting","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2623533639","pubTimestamp":1774969740,"columns":[],"sourceInfo":{"source_id":"benzinga_hot_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Shares of IO Biotech, Inc. (NASDAQ: IOBT) are plummeting after the company announced it filed for Chapter 7 bankruptcy and will cease operations in Delaware.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4585":"ETF&股票定投概念","XBI":"SPDR S&P Biotech ETF","BK4139":"生物科技","IOBTQ":"IO Biotech, Inc.","BK4581":"高盛持仓","IOBT":"IO Biotech, Inc."},"translate_title":"IO Biotech股价为何暴跌？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XBI":1.5,"IOBTQ":1.5,"IOBT":1.5},"content_text":"IO Biotech's sell-off is being treated as an insolvency event, not a routine small-cap biotech de-risking, after the company filed for Chapter 7 bankruptcy and said it will cease operations in Delaware. The stock fell about 73% to roughly $0.046 alongside that disclosure.\nThe price action is consistent with a stock that has been in a prolonged downtrend and is now breaking to fresh lows, which can trigger forced selling and liquidity-driven air pockets. With small-cap risk appetite improving elsewhere (Russell 2000 up 2.05% and market breadth positive with 9 sectors advancing), the disconnect points to stock-specific positioning and technical damage rather than a sector-wide move.\nFrom a chart perspective, IOBT is also trading far below its key trend gauges, so even modest selling pressure can have an outsized impact when there's no nearby technical \"floor\" traders trust. That dynamic often shows up when a name is pressing new lows and prior support levels have already failed.\nIOBT is trading 81.5% below its 20-day simple moving average (23 cents) and 91.6% below its 100-day SMA (51 cents), keeping both the short- and intermediate-term trends firmly bearish. Shares are down 96.09% over the past 12 months and are positioned much closer to their 52-week lows than highs.\nRSI in the 30–50 range with bullish MACD indicates momentum leaning bullish, but it's fighting a deeply bearish trend backdrop. Key resistance currently sits at 50 cents with no clear support defined given the sharp sell-off.\nIOBT Stock Price Activity: IO Biotech shares were down 75.41% at $0.045 at the time of publication on Tuesday, according to Benzinga Pro data.\nImage: Shutterstock\nTo add Benzinga News as your preferred source on Google, click here.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2623533639","isCrawlerRequest":true}